Dr. David Litt, MD

NPI: 1265403240
Total Payments
$3,821
2024 Payments
$745.84
Companies
31
Transactions
271
Medicare Patients
6,660
Medicare Billing
$737,058

Payment Breakdown by Category

Food & Beverage$3,821 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,821 271 100.0%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $1,051 100 $0 (2024)
Novo Nordisk Inc $532.43 31 $0 (2024)
ABBVIE INC. $531.29 36 $0 (2024)
GlaxoSmithKline, LLC. $295.35 17 $0 (2024)
Astellas Pharma US Inc $251.63 15 $0 (2024)
Merck Sharp & Dohme LLC $107.45 7 $0 (2024)
E.R. Squibb & Sons, L.L.C. $104.90 8 $0 (2021)
Janssen Pharmaceuticals, Inc $100.12 7 $0 (2020)
Boehringer Ingelheim Pharmaceuticals, Inc. $98.58 7 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $79.47 5 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $745.84 57 PFIZER INC. ($240.54)
2023 $773.89 59 PFIZER INC. ($244.76)
2022 $564.51 37 Novo Nordisk Inc ($164.57)
2021 $589.47 43 PFIZER INC. ($264.42)
2020 $187.18 13 PFIZER INC. ($52.82)
2019 $328.66 20 AbbVie, Inc. ($43.58)
2018 $362.69 24 PFIZER INC. ($63.65)
2017 $268.85 18 GlaxoSmithKline, LLC. ($65.24)

All Payment Transactions

271 individual payment records from CMS Open Payments — Page 9 of 11

Date Company Product Nature Form Amount Type
03/17/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.38 General
Category: GASTROENTEROLOGY
02/20/2020 Teva Pharmaceuticals USA, Inc. AJOVY (Biological) Food and Beverage In-kind items and services $12.83 General
Category: Central Nervous System
02/13/2020 Astellas Pharma US Inc MYRBETRIQ (Drug) Food and Beverage In-kind items and services $15.30 General
Category: UROLOGY
02/12/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.82 General
Category: GASTROENTEROLOGY
02/06/2020 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $12.31 General
Category: Diabetes
01/31/2020 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $12.36 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
01/24/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug), XIFAXAN Food and Beverage In-kind items and services $14.60 General
Category: GASTROENTEROLOGY
01/23/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug), INVOKANA Food and Beverage In-kind items and services $16.57 General
Category: Cardiovascular & Metabolism
01/16/2020 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $14.79 General
Category: CARDIOVASCULAR
11/26/2019 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.49 General
Category: GASTROENTEROLOGY
10/31/2019 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $20.94 General
Category: Anemia
10/24/2019 PFIZER INC. PREVNAR - 13 (Biological) Food and Beverage In-kind items and services $13.66 General
Category: VACCINES
10/03/2019 Lilly USA, LLC BASAGLAR (Drug), TRULICITY, JARDIANCE Food and Beverage In-kind items and services $17.75 General
Category: Diabetes
09/26/2019 Boehringer Ingelheim Pharmaceuticals, Inc. SPIRIVA RESPIMAT (Drug) Food and Beverage In-kind items and services $15.68 General
Category: RESPIRATORY
09/06/2019 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $13.31 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
08/29/2019 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $11.88 General
Category: CARDIOVASCULAR
08/08/2019 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $14.07 General
08/01/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $12.62 General
Category: Cardiovascular & Metabolism
07/25/2019 AbbVie, Inc. Creon (Drug) Food and Beverage In-kind items and services $20.94 General
Category: Endocrinology
07/11/2019 Merck Sharp & Dohme Corporation JANUVIA (Drug), JANUMET, JANUMET XR Food and Beverage In-kind items and services $11.13 General
Category: ENDOCRINOLOGY
06/27/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $15.04 General
Category: Cardiovascular & Metabolism
05/23/2019 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $23.66 General
Category: Diabetes
05/16/2019 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $14.79 General
Category: CARDIOVASCULAR
04/18/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $13.89 General
Category: Cardiovascular & Metabolism
03/21/2019 Astellas Pharma US Inc VESICARE (Drug), MYRBETRIQ Food and Beverage In-kind items and services $17.27 General
Category: UROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 20 1,865 2,217 $283,313 $221,081
2022 24 1,567 1,878 $220,907 $164,874
2021 24 1,651 2,148 $255,530 $190,375
2020 21 1,577 2,052 $219,420 $160,728
Total Patients
6,660
Total Services
8,295
Medicare Billing
$737,058
Procedure Codes
89

All Medicare Procedures & Services

89 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 219 219 $66,795 $61,900 92.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 304 304 $45,600 $40,678 89.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 268 430 $62,350 $40,313 64.7%
90662 Influenza vaccine split virus, preservative free Office 2023 181 184 $14,900 $13,194 88.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 23 98 $13,034 $9,540 73.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 63 68 $15,640 $9,243 59.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 58 137 $12,467 $8,823 70.8%
G0009 Administration of pneumococcal vaccine Office 2023 222 222 $6,660 $6,527 98.0%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 51 60 $8,640 $5,645 65.3%
G0008 Administration of influenza virus vaccine Office 2023 184 187 $5,610 $5,498 98.0%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 22 22 $4,180 $3,769 90.2%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 20 20 $3,800 $3,420 90.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 45 49 $5,390 $3,380 62.7%
99496 Transitional care management services for problem of high complexity Office 2023 13 13 $4,030 $2,980 73.9%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2023 40 43 $3,870 $1,776 45.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 16 16 $2,832 $1,697 59.9%
99212 Established patient office or other outpatient visit, 10-19 minutes Facility 2023 29 36 $2,520 $1,049 41.6%
99202 New patient office or other outpatient visit, 15-29 minutes Facility 2023 20 20 $1,700 $788.80 46.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 53 54 $2,700 $566.35 21.0%
36415 Insertion of needle into vein for collection of blood sample Office 2023 34 35 $595.00 $294.00 49.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 269 426 $61,770 $41,490 67.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 296 296 $44,400 $40,745 91.8%
90662 Influenza vaccine split virus, preservative free Office 2022 178 178 $13,350 $12,132 90.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 93 147 $13,286 $8,620 64.9%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 68 69 $12,213 $7,748 63.4%

About Dr. David Litt, MD

Dr. David Litt, MD is a Internal Medicine healthcare provider based in Meadowbrook, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265403240.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Litt, MD has received a total of $3,821 in payments from pharmaceutical and medical device companies, with $745.84 received in 2024. These payments were reported across 271 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,821).

As a Medicare-enrolled provider, Litt has provided services to 6,660 Medicare beneficiaries, totaling 8,295 services with total Medicare billing of $737,058. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Meadowbrook, PA
  • Active Since 01/30/2006
  • Last Updated 07/18/2014
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1265403240

Products in Payments

  • ELIQUIS (Drug) $673.80
  • PREVNAR 20 (Biological) $266.90
  • Ozempic (Drug) $209.87
  • Rybelsus (Drug) $204.02
  • UBRELVY (Drug) $197.50
  • TRELEGY ELLIPTA (Drug) $180.58
  • VRAYLAR (Drug) $148.07
  • CHANTIX (Drug) $116.40
  • ANORO (Drug) $102.05
  • QULIPTA (Drug) $100.79
  • XARELTO (Drug) $100.12
  • MYRBETRIQ (Drug) $85.65
  • Creon (Drug) $84.93
  • XIFAXAN (Drug) $78.32
  • Veozah (Drug) $70.08
  • Cologuard Collection Kit (Device) $63.35
  • Myrbetriq (Drug) $60.79
  • ENTRESTO (Drug) $56.49
  • TRUMENBA (Biological) $44.13
  • NUEDEXTA (Drug) $42.92

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Meadowbrook